Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:


Articles on the impact, diagnosis and treatment of the novel coronavirus and COVID-19

CanSino Publishes Positive Data from COVID-19 Vaccine Trial in The Lancet

Sinovac Raises $15 Million for Phase II Trials of COVID-19 Vaccine

CanSino Developing mRNA COVID-19 Vaccine with Precision NanoSystems

Moderna Reports Early Positive Results in Trial of Coronavirus Vaccine

Sorrento Announces Antibody that Inhibits 100% of SARS-CoV-2 Virus Infection

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China